Učitavanje...
Delta‐Like Protein 3 Expression and Targeting in Merkel Cell Carcinoma
PURPOSE: Delta‐like protein 3 (DLL3) is being developed as a predictive biomarker for DLL3‐targeting antibody‐drug conjugate and other therapies. Given the neuroendocrine features of Merkel cell carcinoma (MCC), we sought to evaluate DLL3 expression and its role in MCC. EXPERIMENTAL DESIGN: Formalin...
Spremljeno u:
| Izdano u: | Oncologist |
|---|---|
| Glavni autori: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Inc.
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7485334/ https://ncbi.nlm.nih.gov/pubmed/32372416 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0877 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|